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Abstract 
Silk fibroin (SF) and gelatin are natural polymers suitable for biomedical applications, including 
controlled protein release. SF offers high mechanical strength and slow enzymatic degradability, 
whereas gelatin contains bioactive motifs that can provide biomimicry to the resulting scaffolds. 
Owing to their complementary material properties, SF and gelatin are increasingly being used 
together to afford hybrid scaffolds with adjustable properties. Here, we report the use of in situ 
crosslinked SF/Gelatin hydrogels as a platform for tunable growth factor sequestration and 
delivery. We demonstrate that the physical assembly of SF into insoluble network could be 
accelerated by sonication even in the presence of gelatin. However, the processing conditions 
from which to prepare SF aqueous solution (e.g., heating duration and number of processing 
steps) drastically altered the resulting hydrogel physical properties. Furthermore, the stiffness of 
SF/Gelatin hybrid gels display temperature dependency. Specifically, incorporation of gelatin 
increased gel stiffness at 25°C but decreases hydrogel mechanical stability at 37°C. The 
thermostability of SF/Gelatin gels can be restored by using low concentration of genipin, a 
naturally derived chemical crosslinker. We also incorporate heparin-conjugated gelatin (GH) into 
the hydrogels to create a hybrid matrix capable of sequestering growth factors, such as basic 
fibroblast growth factor (bFGF). Both sonicated SF (SSF) and hybrid SSF-GH gels exhibit 
moderate bFGF sequestration, but only SSF-GH gels afford slow release of bFGF. On the other 
hand, genipin-stabilized network exhibited the highest retention and sustained release of bFGF, 
suggesting the suitability of this particular formulation as a scaffold for tissue engineering 
applications. 
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Introduction 
Hydrogels are ideal for in vitro cell culture owing to their high water content and tunable 
material properties that can mimic the extracellular matrix (ECM). Naturally-derived 
biomacromolecules, such as silk fibroin (SF) and gelatin, are increasingly used for hydrogel 
fabrication as these molecules possess biologically relevant structure and function that emulate 
aspects of ECM properties.1 SF derived from Bombyx mori silkworm cocoons is an appealing 
material for biomedical applications because of its biocompatibility, high tensile strength, slow 
enzymatic degradation, and versatile processing methods to produce scaffolds with a variety of 
forms and shapes.2,3 SF has been formulated into hydrogels for 3D cell culture4-6, particles for 
drug loading and delivery7, and spun fibers for scaffolding materials.8 
Among the various gelation mechanisms, chemical crosslinking is ideal for biomedical 
applications requiring long-term network stability. However, modifying SF chemically is 
challenging due to its hydrophobicity and poor solvent solubility. SF is composed of paired 
heavy and light chains linked by a disulfide bond.9,10 The primary structure of SF heavy chain is 
mostly hydrophobic owing to the Gly-X repeats (X being primarily Ala and Ser).2,7,10 Despite its 
hydrophobicity, SF can be prepared in aqueous solution through high salt and ethanol-based 
dissolution and dialysis processes. Solubilized SF exhibits strong intra- and intermolecular 
interactions, which facilitate their self-assembly into anti-parallel β-sheets and ultimately lead to 
physical gelation.2,4,6,11,12 These processes, however, can take several hours to days, depending 
on SF concentration, solution compositions, and storage conditions.12 Physical gelation could be 
accelerated by exposing SF to methanol, which dehydrates the protein chains and accelerates 
the formation of β-sheet crystalline domains.13,14 Physical gelation of SF can also be accelerated 
by sonication,6 which forgoes the use of methanol whose residual presence in the SF network 
could pose cytotoxic effect on cells.4,6 Sonication also has an added benefit of decreasing the 
time of SF physical gelation from days to hours or even minutes6,15 because it causes cavitation 
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and elevated temperature, pressure, and strain rate, all of which disrupt water molecules 
surrounding the SF protein chains and accelerate SF self-assembly.4,6,16 SF gelation kinetics 
can be readily tuned by adjusting the sonication duration and intensity.6,15  
Another natural macromolecule commonly used to fabricate hydrogels is gelatin, a 
collagen-derived water-soluble protein. Gelatin is a popular choice in hydrogel fabrication 
because it contains peptide sequences for cell adhesion (e.g., integrin binding sites RGD) and 
protease-mediated cleavage (e.g., substrates for matrix metalloproteinase (MMPs)).4,17 Gelatin 
experiences thermo-reversible physical gelation, where it is a gel at room temperature and 
undergoes gel-sol transition at an elevated temperature (e.g., 37°C).18 Gelatin can be 
chemically modified to provide additional features (e.g., heparinization17 or PEGylation19) or to 
provide covalently crosslinkable motifs (e.g., methacrylates20, norbornene17,20, etc.). For 
example, via carbodiimide chemistry17,21,22, the amino groups on gelatin can be conjugated with 
carboxyl groups on heparin, a sulfated glycosaminoglycan that binds to various growth factors 
for controlling their bioavailability and for protecting them from proteolysis.23-25 Sequestering 
growth factors by heparin near the cell surface provides a mechanism for controllable 
amplification of specific growth factor signaling to direct cell fate. For example, our laboratory 
has reported an orthogonal thiol-ene crosslinked gelatin-heparin hybrid hydrogel for studying the 
effect of matrix properties on hepatocellular carcinoma cell fate in vitro.17 In that application, 
gelatin was dually functionalized with norbornene and heparin. While the norbornene motif 
affords facile thiol-ene crosslinking, the conjugated heparin permits binding and slow release of 
hepatocyte growth factor (HGF).  
Recently, silk fibroin and gelatin were combined to form hybrid hydrogels through 
different crosslinking mechanisms. For example, Das et al. used an SF-gelatin blend as bioink 
for bioprinting three-dimensional SF-gelatin hydrogel constructs to study multi-lineage 
differentiation of stem cells.4 The bioprinted SF-gelatin hydrogels were crosslinked via either 
sonication or tyrosinase-mediated enzyme crosslinking. In another example, genipin was used 
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to crosslink SF-gelatin hybrid hydrogels for studying stem cell behavior.26 One common feature 
of these prior studies was that SF provides mechanical strength and stability, whereas gelatin 
lends its bioactive motifs for promoting cell-materials interactions. Additionally, gelatin could be 
modified with heparin conjugates to affect cell fate in vitro via growth factor sequestration and 
signaling.23  
In this contribution, we report the development of an in situ crosslinked hydrogel platform 
using sonicated SF (i.e., SSF) and gelatin (i.e., G) or heparin-conjugated gelatin (i.e., GH). This 
hybrid hydrogel system differs from previously presented SF/Gelatin hydrogels by employing 
sonicated SF to entrap bioactive gelatin or heparin-conjugated gelatin, thus providing additional 
control of growth factor sequestering and release over time. This system also differs from 
previous SF/Gelatin gels by using genipin as the secondary crosslinking mechanism to reinforce 
the hybrid hydrogels. We systematically evaluated the gelation kinetics of sonicating SF-
reinforced hybrid hydrogels. The effect of macromer concentration and SF processing 
conditions on gel modulus, as well as the effect of gelatin on physical gelation kinetics, were 
evaluated via rheometry. We further examined the thermostability of the hybrid hydrogels in the 
absence or presence of additional genipin crosslinking. Additionally, retention of GH and 
fibroblast growth factor basic (bFGF) in the hydrogels were quantified to assess the suitability of 
this class of hybrid matrix as a growth factor delivery vehicle.  
 
 
Materials and Methods 
Materials 
Type A Gelatin (Bloom 238-282) was obtained from Amresco. Heparin sodium salt was 
obtained from Celsius Laboratories. 1-(3-(Dimethyl amino) propyl)-3-ethylcarbodiimide 
hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were obtained from Fisher and TCI 
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chemicals, respectively. Genipin was obtained from Enzo Life Sciences. Recombinant human 
bFGF and Mini ABTS ELISA Development Kit were obtained from Peprotech. 1,9-Dimethyl-
methylene blue (DMMB) was obtained from Sigma-Aldrich. All other chemicals were obtained 
from Fisher Scientific unless otherwise noted. 
 
Preparation of SF Aqueous Solution 
Silk fibroin was purified from Bombyx mori silkworm as previously described.27,28 Two types of 
SF were used in this work: degummed SF (D-SF) and regenerated SF (R-SF). D-SF describes 
the silk fibroin protein after the removal of sericin from silk worm cocoons. On the other hand, R-
SF designates SF produced from degummed SF solution that was lyophilized and stored for 
later use. R-SF and was prepared as previously described.29 To solubilize SF, D-SF was 
dissolved at 6 wt % in aqueous solution composed of 9.3 M CaCl2, and 20% (v/v) of absolute 
ethanol (molar ratio of CaCl2: H2O: ethanol = 1:8:2). The solution was refluxed at 95°C for 1 h, 
cooled to room temperature, filtered, and dialyzed against ddH2O (MWCO 6-8 kDa, Fisher) for 3 
days to remove the salts. Following dialysis, the SF solution (still within the dialysis membrane) 
was concentrated in a bath of dry poly (ethylene glycol) (PEG, 10 kDa). The final concentration 
of SF solution (5 – 6 wt/vol %) was determined gravimetrically by drying a small sample of 
dialyzed and concentrated SF solution. Sonication of SF solution was performed using a 
Branson S450 Sonifier. Regenerated SF solution was sonicated at 25% amplitude for 25 s pulse 
(5 s on, 2 s off), and degummed SF solution at 20% amplitude for 5 s. 
 
Fabrication of SSF/Gelatin Physical Hydrogels 
Prepolymer solution was prepared in pH 7.4 PBS containing SSF and gelatin or GH. In select 
experiments, genipin (GN, final concentration at 0.1 wt %) was added to provide partial 
chemical crosslinking for improving the stability of the hybrid network. Hydrogels were formed 
between two glass slides separated by 1 mm thick Teflon spacers.30 The glass slides containing 
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prepolymer aliquots were incubated at room temperature for 24 hours within a humidified 
chamber. 
 
Synthesis, Characterization, and Retention of GH by SSF-GH Hydrogels 
Heparin was conjugated onto type A gelatin through standard carbodiimide chemistry following 
an established protocol.17 The degree of heparin substitution (DS) was quantified by DMMB 
assay using unmodified heparin sodium salt solutions as standards. The results were quantified 
using a microplate reader (abs 525 nm) and determined to be about 0.5% (~5 µg heparin per 1 
mg of gelatin). GH retention by SSF-GH gels was evaluated by DMMB assay. Briefly, SSF-GH 
and SSF-GH-GN gels were prepared as described above, except one group of SSF-GH-GN 
gels was allowed to crosslink at 37°C for 24 hours. Gels were incubated in 3 mL pH 7.4 PBS at 
37°C for 72 hours. At 24 hour intervals, 500 µL of solution was collected and replaced with fresh 
PBS to maintain total solution volume. Samples were stored at -20°C until analysis by DMMB 
assay as described above.  
 
In Situ Physical Gelation  
To evaluate gelation kinetics, in situ rheometry was performed in time-sweep mode on a Bohlin 
CVO 100 digital rheometer. Gel point was defined as the time at which storage modulus (G’) 
surpasses loss modulus (G’’). Immediately post-sonication, prepolymer solution was aliquoted 
between the rheometer platform and 8mm parallel plate geometry. The rim of the geometry was 
lightly sealed with mineral oil to prevent drying. Time-sweep rheometry was operated at 0.5% 
strain, 1 Hz frequency, 90 µm gap size, and at 37°C (temperature controlled by a Peltier 
controller).  
 
Characterization of Gel Properties 
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G’ and G’’ of SSF/Gelatin hybrid hydrogels were measured using a Bohlin CVO 100 digital 
rheometer in oscillatory strain-sweep (0.1 – 2%) mode with 8 mm parallel plate geometry at 1Hz 
frequency and 680 µm gap size. With a Peltier controller, the effect of temperature on gel 
modulus was evaluated (0.5% strain, 1 Hz frequency) at a temperature range of 25 to 37°C.  
 
In Vitro bFGF Sequestering and Release from Hybrid Hydrogels 
The SSF, SSF-G, SSF-GH, SSF-GH-GN hydrogels (compositions listed in Table 1) were 
prepared in 96-well plates for the bFGF sequestering and release experiments. 50 µL of 
prepolymer solutions were added per well. The plates were sealed and incubated for 24 hours 
at room temperature. For sequestration study, gels were cast in 96-well plate, followed by 
adding 250 µL of bFGF solution (3 ng/mL in pH 7.4 PBS containing 0.1% BSA) in each well. 
The plate was sealed and incubated at 37°C for 24 hours. After incubation, the release buffer 
with bFGF was collected and replaced with 250 µL fresh release buffer (0.1% BSA in pH 7.4 
PBS) per well. This process was repeated at 48 and 72 hours of incubation. Immediately 
following collection, the samples were stored at -80°C until analysis with Human FGF-basic Mini 
ABTS ELISA Development Kit following manufacturer’s protocol. Results were displayed as 
percentages of the total bFGF originally introduced either in solution or within the gels. Release 
study was performed as described above, except recombinant human bFGF (3 ng/mL) were 
added to prepolymer solutions and not included in the release buffer. 
 
Table 1. Hydrogel Formulations used in Figures 5-7. All numbers indicate the final wt% of each 
component in the hydrogels. 
Group SSF SSF-G SSF-GH SSF-GH-GN 
Sonicated silk fibroin (SSF) 3 3 3 3 
Gelatin (G) 0 3 0 0 
Gelatin-heparin (GH) 0 0 3 3 
Genipin (GN) 0 0 0 0.1 
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Statistics 
All statistical analyses and curve fittings were conducted using GraphPad Prism 5 software. Gel 
modulus, and gel point were analyzed by One-Way ANOVA followed by Tukey’s post-hoc test. 
Heparin and bFGF retention were analyzed by Two-Way ANOVA followed by Bonferroni post-
hoc test. All data was presented as Mean ± SEM. Single, double, and triple asterisks represent 
p<0.05, 0.001, and 0.0001, respectively. p <0.05 was considered statistically significant. 
 
Results and Discussion 
Effect of Sonication on Physical Gelation of SF/Gelatin Hydrogels 
The primary goal of the current study was to fabricate in situ forming silk-gelatin hybrid 
hydrogels suitable for growth factor sequestration and delivery. Unlike a previous work by our 
laboratory that used sonicated SF (SSF) physical gelation as a secondary mechanism to stiffen 
chemically crosslinked hydrogels29, physical gelation was the main focus of this work. While 
sonication has been shown to accelerate physical gelation of SF, it is not clear whether the 
presence of gelatin in the mixture would adversely affect the physical gelation of the hybrid 
hydrogels. Here, we performed conventional tilt tests to demonstrate the influence of sonication 
and/or gelatin incorporation on physical gelation of SF (Fig. 1). Solutions of pure regenerated 
SF, and SF-Gelatin (SF-G) were incubated at 37°C. As shown in Fig. 1A, both SF and SF-G 
were still in solution after 2 hours of incubation. Conversely, SSF and SSF-G appeared to gel by 
20 minutes of incubation (Fig. 1B). Sonication causes localized increases in temperature, 
pressure, and strain rate that accelerate SF self-assembly.4,6,16 This simple tilt test showed that 
the presence of gelatin did not adversely impact physical gelation of sonicated SF. To 
understand the influence of gelatin incorporation on SSF physical gelation, additional rheometry 
studies were performed (see section below).  
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Figure 1. Tilt tests of SF physical gelation using (A) pure SF solution without or with gelatin (SF and SF-
G, respectively), and (B) sonicated (25% amplitude, 25 s pulse) SF solution without or with gelatin (SSF 
and SSF-G, respectively). Components were added at 3 wt % for SF and SSF and 6 wt % for SF-G and 
SSF-G (equal weight ratio of SF and gelatin). 
 
 
Effect of SSF and Gelatin Content on Gel Modulus 
To quantitatively assess the effect of SSF and gelatin contents on physical gelation of the hybrid 
hydrogels, we prepared gels with 1 – 3 wt % of SSF at constant gelatin content (i.e., 3 wt %) or 
0 – 4 wt % gelatin at constant SSF content (i.e., 3 wt %) and conducted shear modulus 
measurements at room temperature (25°C). For the oscillatory rheometry studies, frequency of 
1 Hz was selected because it lies within the linear region of SSF gel frequency response curve 
(Fig. S1). Note that without SSF, pure gelatin at below 4 wt % could not gel at ambient 
temperature. Prior to mixing SF with gelatin, regenerated SF solution (R-SF) was sonicated at 
25% amplitude for 25 s pulse mode (5 s on, 2 s off). After mixing in gelatin at desired 
concentration, the mixture solution was pipetted into the glass slides assembly and allowed to 
form physical gels in a humidified chamber overnight. While 20 min at 37°C was sufficient for 
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sol-gel transition when SSF was incorporated (Fig. 1B), we used longer incubation time at 25°C 
for the modulus testing to ensure complete gelation. To assess the effect of SSF concentration 
on gelation, we measured moduli of the physical gels with varying SSF concentration (1 – 3 wt 
%) while holding gelatin concentration constant (3 wt %). Not surprisingly, gel moduli increased 
significantly with increasing SSF concentration. Specifically, there was an approximately 6-fold 
increase in gel shear modulus when SSF content was increased from 1 wt % to 3 wt % (G’ = 
1,181 ± 30 Pa, 3,461 ± 141 Pa, and 7,573 ± 398 Pa for 1, 2, and 3 wt % SSF, respectively. Fig. 
2A). Next, we evaluated the effect of gelatin incorporation on the mechanical properties of the 
hybrid hydrogels using constant SSF content (i.e., 3 wt %). Increasing gelatin content from 0 to 
4 wt % caused an approximately 4-fold increase in G’ (G’ = 2,320 ± 134 Pa, 6,652 ± 178 Pa, 
7,573 ± 398 Pa, and 10,057 ± 128 Pa for 1, 2, 3, and 4 wt % gelatin, respectively. Fig. 2B). 
Increase in SSF content caused a greater increase in G’ as compared with an equivalent 
increase in gelatin content since semi-crystalline SF β-sheets provided greater mechanical 
stability than amorphous gelatin.11 It is worth noting that gels with lower SSF concentration, 
particularly at 1 wt %, were too brittle and difficult to handle without breaking. Based on these 
results, a single formulation (3 wt % SSF + 3 wt % G) was chosen for all subsequent 
experiments unless otherwise stated. These formulations also yield gels with physiologically 
relevant moduli (i.e., ~1-10kPa). 
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Figure 2. (A) Effect of SSF content on shear modulus (G’) of SSF-G hydrogels with constant gelatin 
concentration (3 wt %) at 25°C. (B) Effect of gelatin concentration on shear modulus of SSF-G hydrogels 
with constant SSF concentration (3 wt %). Data represent Mean ± SEM (n = 5); ***p<0.0001. 
 
Effect of SF Solution Processing on Hydrogel Physical Properties 
Fig. 1 and Fig. 2 show that sonication accelerates silk physical gelation and that increasing SSF 
or gelatin concentration increases gel stiffness. Gel physical properties can also be affected by 
altering SF processing conditions. Several processing steps are necessary to obtain aqueous 
SF solution suitable for biomedical applications. The solvent system, temperature and duration 
of dissolution, storage conditions, as well as intensity and duration of sonication all affect the 
properties and behavior of aqueous SF. To illustrate the effect of SF solution processing 
conditions on SF hydrogel physical properties, we compared the moduli of pure SF hydrogels (3 
wt % SSF) fabricated from sonicated regenerated-SF (R-SSF) and sonicated degummed-SF (D-
SSF). In particular, D-SSF hydrogels presented about 3-fold higher G’ than R-SSF gels (G’ = 
2,320 ± 134 Pa and 8,572 ± 306 Pa for R-SSF and D-SSF, respectively. Fig. 3). In this study, 
D-SF was refluxed for 1 hour at 95°C while the R-SF was derived from SF that was refluxed for 
longer than 2 hours. The increased dissolution duration causes a higher degree of SF protein 
breakdown leading to lower molecular weight SF.31,32 While R-SF solution was sonicated at 25% 
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amplitude for 25 s pulse (5 s on, 2 s off), D-SF was only sonicated at 20% amplitude for 5 s. 
Attempting to sonicate D-SF using the same conditions as for R-SF resulted in rapid gelation of 
D-SSF during sonication. The objective of sonication was to accelerate gelation of SSF, while 
still allowing SSF to be soluble long enough for preparing the prepolymer solution. Sonication 
parameters for R-SSF were selected based upon a previous work29 but slightly increased to 
accelerate gelation even more. Sonication at 20% amplitude for 5 s was selected for D-SSF 
because sonication with higher intensity or duration caused the silk to gel during, or seconds 
after sonication. Since D-SSF exhibited higher gelation efficiency compared with R-SSF, it was 
used in the subsequent experiments. 
 
 
Figure 3. Effect of SF solution processing conditions on shear modulus (G’) of pure SSF physical 
hydrogels (R-SSF: regenerated SSF, D-SSF: degummed SSF). Data represent Mean ± SEM (n = 5); 
***p<0.0001. 
 
Physical Gelation Kinetics of SSF/Gelatin Hydrogels 
We investigated whether the presence of gelatin or gelatin-heparin (i.e., GH) would accelerate 
physical gelation kinetics of SSF hydrogels (Fig. 4). Real time in situ rheometry was conducted 
at 37°C immediately after mixing the solution components with pure gelatin (Fig S2A) or pure 
R-
SS
F
D-
SS
F
0
3000
6000
9000
12000
***
G
' (
Pa
)
14 
 
SSF (Fig. 4A) as controls. The gel point (the time at which G’ exceeds G’’) is a metric of when 
the sol-gel transition occurs and was identified from the in situ rheometry results. In situ 
rheometry results show that all formulations tested, except for 3 wt% of pure gelatin (Fig. S2A), 
formed physical hydrogel at 37°C. Specifically, gel point for SSF (Fig. 4A), SSF-G (Fig. 4B), 
and SSF-GH (Fig. 4C) was 764 ± 47, 270 ± 25, and 374 ± 34 s, respectively (Fig. S2B). 
Notably, the inclusion of gelatin or GH accelerated the gelation kinetics. Although gelatin by 
itself did not gel under the testing conditions (Fig. S2A)18, it did act as a crowding agent for the 
SSF chains and increase their local concentration that led to accelerated gelation.15,29 GH also 
accelerated SSF gelation, but to a lesser extent than unmodified gelatin. This is potentially due 
to charge repulsion between the negatively charged heparin and SSF that disrupted the folding 
of SF β-sheets and slowed the self-assembly process.33 
 
 
Figure 4. In situ rheometry of SSF (A), SSF-G (B), and SSF-GH (C). All rheometry experiments were 
conducted at 37°C. Compositions of the macromer solutions were 3wt % SSF and/or 3wt % G/GH. Data 
shown were representative of at least three independent experiments for each condition.  
 
Effect of Temperature on SSF/Gelatin Hydrogel Modulus 
Previous measurements of G’ to determine average gel stiffness (Figs 2 and 3) were carried 
out at room temperature (i.e., 25°C). However, these silk fibroin-gelatin gels are intended for 
applications under physiological temperatures where gelatin is likely unstable due to its thermo-
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reversibility. Hence, the effect of temperature on gel modulus was evaluated in real time (Fig. 
5A) and as average values at 25°C and 37°C (Fig. S3). While SSF gels were thermostable with 
little change in modulus within the testing temperatures, the incorporation of gelatin or GH 
decreased gel modulus noticeably when the temperature were raised above ~32°C. Due to the 
thermo-reversible nature of gelatin physical crosslinking, modulus of SF-G hydrogels was also 
temperature dependent. To improve thermostability of the physical silk fibroin-gelatin hydrogels, 
genipin (0.1 wt % final conc.) was incorporated in the prepolymer mixture. Genipin is a natural 
crosslinker derived from geniposide, a compound found in gardenia fruit26 and has been used to 
covalently crosslink proteins with abundant primary amine groups (e.g., gelatin and silk 
fibroin).5,26,34 Typically, the standard reaction time allowed for genipin crosslinking has been 
approximately 24 hours.5,26,34 For example, Bigi et al. showed that a high degree of gelatin 
crosslinking occurs after 24 hours with 0.15 wt % genipin.34 As shown in Fig. 5B, the addition of 
genipin improved SSF-GH-GN hydrogel thermostability, most likely a result due to genipin-
induced crosslinking.35-37 Since silk fibroin has relatively few primary amines for genipin to react 
with, the majority of crosslinking would occur within gelatin chains.5  
 
 
Figure 5. Thermostability of silk fibroin-gelatin physical gels (A) and the effect of genipin crosslinking on 
thermostability (B). Shear moduli (G’) of gels were measured over 300 s with temperature increasing from 
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25°C to 37°C. Data represent Mean of three independent experiments for each formulation. Error bars 
were omitted for clarity of results. 
 
GH Retention in SSF-GH Hydrogels 
Fig. 5 shows that physically entrapped gelatin or GH caused decreased stability of the hybrid 
hydrogels and this might lead to leaching of G or GH from the physical hydrogels. The retention 
of GH within the SSF-GH hydrogels was particularly important as it would affect the 
sequestration of growth factors. To this end, GH retention was qualitatively evaluated by a 
modified DMMB assay (Fig. S4).17 After 24 hours incubation in DMMB solution, dark pink 
precipitates formed on top of the SSF-GH gels, indicating the formation of DMMB/heparin 
complex. This formation of DMMB/heparin complex over the SSF-GH gels also signified the low 
retention of GH within the physical hydrogels. Low GH retention was of particular concern given 
the assay was carried out at 25°C and the loss of GH would be even more pronounced at 
physiological temperatures due to gel-sol transition of gelatin. We hypothesized that additional 
genipin crosslinking would limit GH leaching from the hydrogels. To test this hypothesis, small 
quantity of genipin (0.1 wt %) was added during physical gelation of SSF-GH and the resulting 
SSF-GH-GN gels were formed at 25°C or 37°C. The SSF-GH-GN hydrogels showed statistically 
significant improvement in heparin (in the form of GH) retention over SSF-GH (Fig. 6). Also, 
SSF-GH-GN crosslinked at 37°C exhibited improved heparin retention over gels crosslinked at 
25°C at 72 hours incubation. However, heparin retention was still less than 50%. This was likely 
due to the low genipin content available for crosslinking and some genipin crosslinking occurred 
between SSF chains.  
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Figure 6. Retention of heparin by SSF-GH hydrogels with (SSF-GH-GN) or without (SSF-GH) genipin 
crosslinking. Data represent Mean ± SEM of three independent experiments for each formulation; 
*p<0.05, **p<0.001, ***p<0.0001. 
  
Sequestering of Basic Fibroblast Growth Factor  
To evaluate the ability of the SSF/Gelatin hybrid hydrogels to sequester and release growth 
factors, we designed two set of experiments: bFGF sequestration (Fig. 7) and sustained release 
(Fig. 8). Growth factor sequestering can be broadly applied during in vitro cell culture to help 
direct cell fate.23 The goal of this study was to obtain high sequestration of growth factor (i.e., 
bFGF) from solution to the surface of the hybrid hydrogel. As shown in Fig. 7B, pure SSF gels 
sequestered about 50% of bFGF from the solution after 24 hours of incubation. The 
sequestration reduced slightly to 42% after 72 hours of incubation. SSF gels were able to 
sequester bFGF because at physiological pH, SF was negatively charged and is attracted to 
positively charged bFGF.33 Conversely, type A gelatin is positively charged at physiological 
pH,18 which repels bFGF and so little to no bFGF is sequestered by the SSF-G gels. When 
gelatin was replaced with gelatin-heparin conjugate (i.e., GH), the resulting SSF-GH hydrogels 
displayed comparable bFGF sequestration to SSF gels (Fig. 7B). The slight decrease in bFGF 
sequestration on SSF-GH gel surface when compared with SSF gels was likely caused by 
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leaching of GH to which bFGF was bound. SSF-GH-GN gels showed the highest sequestration 
of bFGF (~70% after 72 hours, Fig. 7B) due to additional genipin crosslinking. The improved 
bFGF sequestration is at least partially due to the improved GH retention from genipin 
crosslinking, presenting more available heparin on the gel surface to sequester bFGF. For all 
groups, the slight decrease in sequestered bFGF after each 24 hour interval was due to the 
release of some surface-sequestered bFGF back to the solution. 
 
 
 
Figure 7. (A) Schematic of human fibroblast growth factor basic (bFGF) sequestering from the buffer to 
the surface of different SF-gelatin hybrid hydrogels. (B) Sequestration of bFGF from buffer solution to the 
gel surface at 24, 48, and 72 h of incubation. Data represent Mean ± SEM (n = 4). 
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Release of Basic Fibroblast Growth Factor 
Sequestration of growth factor onto hydrogel surface is useful in promoting cell attachment, 
proliferation, and/or differentiation when the gel matrix is used as a substrate for 2D cell culture. 
On the other hand, sustained release of growth factors from hydrogels is useful for promoting 
tissue regeneration. The objective of this study was to evaluate the release of bFGF from 
different SF-based hydrogels. Here, bFGF was initially encapsulated in the hydrogels during the 
gelation process, followed by gradual release into the buffer covering the gel (Fig. 8A). As 
shown in Fig. 8B, the release of bFGF from SSF gel was only about 13% of total bFGF loaded 
in the hydrogel after 72 hours. The limited release of bFGF from SSF gels was likely caused by 
the molecular attraction occurring between oppositely charged bFGF and SF, and/or 
entrapment of bFGF in the SSF β-sheet crystalline domains. When gelatin was added in the 
hybrid hydrogel (i.e., SSF-G), bFGF release reached ~80% after 72 hours (Fig. 8B), which 
could be explained by the charge repulsion effect between gelatin and bFGF as described 
earlier. It was also possible that gelatin was soluble at 37°C, which led to low retention (and 
hence high % release) of most bFGF within the gels. The incorporation of heparinized gelatin 
into the hybrid hydrogel (i.e., SSF-GH) reduced the amount of bFGF release (~55% after 72 
hours), confirming the growth factor binding capability of the immobilized heparin. Finally, SSF-
GH-GN gels showed the lowest degree of bFGF release (i.e., ~40% after 72 hours, Fig. 8B) 
among all gelatin-containing gels. This was likely due to genipin-mediated GH retention, and 
hence bFGF sequestration, in the hybrid hydrogel network.  
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Figure 8. (A) Schematic of bFGF release from the silk fibroin-gelatin gels into the solution. (B) Release of 
bFGF from silk fibroin-gelatin gels at 24, 48, and 72 hours of incubation. Data represent Mean ± SEM (n = 
4). 
 
 
Conclusion 
In summary, we have developed a simple in situ forming silk fibroin-gelatin hybrid hydrogel 
system as a platform for growth factor delivery. At room temperature, increasing silk fibroin and 
gelatin concentration increased gel moduli. However, at physiological temperature the presence 
of gelatin and heparin-conjugated gelatin accelerated SSF gelation, but decreased gel moduli. 
Hydrogels containing gelatin or gelatin-heparin had decreased stability at physiological 
temperature and significant leaching of GH was detected in SSF-GH hydrogels after 72 hours of 
incubation. On the other hand, hydrogel thermostability and GH retention were improved upon 
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introducing low concentrations of genipin, which formed chemical crosslinks to stabilize the 
physical gels. In terms of growth factor sequestration, providing additional genipin crosslinking 
improved the sequestration of bFGF from ~30% (SSF-GH) to ~75% (SSF-GH-GN) after 72 
hours. Genipin crosslinking also slowed bFGF release from 55% (SSF-GH) to ~40% (SSF-GH-
GN) after 72 hours. In addition to serving as a carrier for sustained growth factor delivery, this 
hybrid hydrogel system can be used for in vitro cell culture. Future work will focus on exploiting 
the growth factor sequestration feature of the system to improve stem cell proliferation and 
differentiation. 
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